Showing results (121-130 of 2,811) with videos related to
Sort By:
Pageof 282
Diabetes Technology & Therapeutics|February 3, 2005
Consumers report glucose meter problems to FDASteven I Gutman, Janie G Fuller, Ethan D HausmanDiabetes Technology & Therapeutics|February 3, 2005
Planning for effective interaction with FDAElizabeth A SpurginDiabetes Technology & Therapeutics|February 3, 2005
Clinical performance of a continuous viscometric affinity sensor for glucosePeter Diem, Lucas Kalt, Ulrich Haueter, et al.Diabetes Technology & Therapeutics|February 3, 2005
IRIS II Study: Sensitivity and specificity of intact proinsulin, adiponectin, and the proinsulin/adiponectin ratio as markers for insulin resistanceMatthias R Langenfeld, Thomas Forst, Eberhard Standl, et al.Diabetes Technology & Therapeutics|February 3, 2005
Thiazolidinediones: a review of their mechanisms of insulin sensitization, therapeutic potential, clinical efficacy, and tolerabilityAbu R Vasudevan, Ashok BalasubramanyamDiabetes Technology & Therapeutics|April 29, 2005
A novel approach to continuous glucose analysis utilizing glycemic variationC M McDonnell, S M Donath, S I Vidmar, et al.Diabetes Technology & Therapeutics|June 3, 2005
Response to nocturnal alarms using a real-time glucose sensorBruce Buckingham, Jen Block, Jonathan Burdick, et al.Diabetes Technology & Therapeutics|June 3, 2005
Real-time glucose sensing using transdermal fluid under continuous vacuum pressure in children with type 1 diabetesJonathan Burdick, Peter Chase, Mark Faupel, et al.Diabetes Technology & Therapeutics|June 3, 2005
Clinical assessment of near-infrared spectroscopy for noninvasive diabetes screeningC D Brown, H T Davis, M N Ediger, et al.Diabetes Technology & Therapeutics|June 3, 2005
The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathyEtta J Vinik, Risa P Hayes, Alan Oglesby, et al.Pageof 282